Revivegen Co (7578.TWO) Stock Price

Revivegen Co Price

CLOSED
25.20TWD-0.30 (-1.18 %)
Market closed

Over the last 7 years Revivegen Co grew revenue by 21.8% annually, reaching 469.23 M TWD. Earnings per share have declined at 27.5% per year over the last 4 years. For Revivegen Co, the net margin of 4.3% is down versus 10.6% a few years ago. At today's price the dividend yield works out to roughly 1.98%. The payout ratio is around 140% of earnings. The stock trades about 2% above its 52-week low.

Revivegen Co stock price

Volume
Ex-Dividend
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Revivegen Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Revivegen Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Revivegen Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Revivegen Co Stock Price History
DateRevivegen Co Price
8/24/202625.20 TWD
8/21/202625.50 TWD
8/20/202626.00 TWD
8/19/202624.60 TWD
8/18/202625.00 TWD
8/17/202626.05 TWD
8/14/202625.80 TWD
8/13/202626.05 TWD
8/12/202626.10 TWD
8/11/202625.70 TWD
8/10/202626.10 TWD
8/7/202626.10 TWD
8/6/202626.50 TWD
8/5/202626.50 TWD
8/4/202625.80 TWD
8/3/202626.10 TWD
7/31/202626.00 TWD
7/30/202625.95 TWD
7/29/202625.90 TWD
7/28/202626.00 TWD
7/27/202627.50 TWD
7/24/202627.60 TWD
7/23/202627.65 TWD
7/22/202627.80 TWD
7/21/202627.95 TWD
7/20/202627.70 TWD
7/17/202628.00 TWD
7/16/202629.00 TWD
7/15/202630.10 TWD
7/14/202630.50 TWD
7/13/202630.45 TWD
7/10/202630.70 TWD
7/9/202630.60 TWD
7/8/202630.70 TWD
7/7/202630.70 TWD
7/6/202630.50 TWD
7/3/202630.75 TWD
7/2/202630.60 TWD
7/1/202630.80 TWD
6/30/202630.60 TWD
6/29/202630.75 TWD
6/26/202630.60 TWD
6/25/202631.00 TWD
6/24/202630.85 TWD
6/23/202630.95 TWD
6/22/202630.95 TWD
6/18/202630.50 TWD
6/17/202630.85 TWD
6/16/202630.95 TWD
6/15/202631.10 TWD
6/12/202631.00 TWD
6/11/202631.50 TWD
6/10/202631.30 TWD
6/9/202632.30 TWD
6/8/202631.30 TWD
6/5/202631.10 TWD
6/4/202631.60 TWD
6/3/202631.85 TWD
6/2/202631.95 TWD
5/29/202632.10 TWD
5/28/202633.00 TWD
5/27/202633.45 TWD
5/26/202633.80 TWD
5/25/202634.55 TWD
5/22/202634.45 TWD
5/21/202632.10 TWD
5/20/202631.70 TWD
5/14/202632.70 TWD
4/2/202633.45 TWD
4/1/202633.90 TWD
3/31/202633.00 TWD
3/30/202634.00 TWD
3/27/202633.50 TWD
3/26/202635.10 TWD
3/25/202634.85 TWD
3/24/202636.40 TWD
3/23/202643.70 TWD
3/20/202631.10 TWD
3/19/202629.90 TWD
3/18/202630.90 TWD
3/17/202630.25 TWD
3/16/202629.50 TWD
3/13/202629.50 TWD
3/12/202629.90 TWD
3/11/202630.10 TWD
3/10/202629.10 TWD
3/9/202629.10 TWD
3/6/202630.10 TWD
3/5/202629.10 TWD
3/4/202628.50 TWD
3/3/202629.60 TWD
3/2/202629.80 TWD
2/26/202630.10 TWD
2/25/202629.95 TWD
2/24/202629.90 TWD
2/23/202630.30 TWD
2/11/202630.40 TWD
2/10/202630.70 TWD
2/9/202630.70 TWD
2/6/202630.90 TWD
2/5/202631.00 TWD
2/4/202630.85 TWD
2/3/202631.10 TWD
2/2/202631.05 TWD
1/30/202630.60 TWD
1/29/202630.95 TWD
1/28/202631.00 TWD
1/27/202630.55 TWD
1/26/202630.50 TWD
1/23/202630.30 TWD
1/22/202630.00 TWD
1/21/202630.90 TWD
1/20/202631.00 TWD
1/19/202631.30 TWD
1/16/202631.00 TWD
1/15/202631.45 TWD
1/14/202631.70 TWD
1/13/202633.10 TWD
1/12/202629.85 TWD
1/9/202629.60 TWD
1/8/202629.40 TWD
1/7/202629.20 TWD
1/6/202629.50 TWD
1/5/202629.80 TWD
1/2/202629.70 TWD
12/31/202530.00 TWD
12/30/202530.00 TWD
12/29/202530.00 TWD
12/26/202529.95 TWD
12/24/202530.00 TWD
12/23/202529.00 TWD
12/22/202528.10 TWD
12/19/202528.30 TWD
12/18/202528.10 TWD
12/17/202528.90 TWD
12/16/202528.90 TWD
12/15/202528.90 TWD
12/12/202528.30 TWD
12/11/202528.30 TWD
12/10/202528.90 TWD
12/9/202528.90 TWD
12/8/202528.60 TWD
12/5/202528.80 TWD
12/4/202528.95 TWD
12/3/202529.15 TWD
12/2/202529.40 TWD
12/1/202529.85 TWD
11/28/202530.55 TWD
11/27/202530.80 TWD
11/26/202528.25 TWD
11/25/202528.25 TWD
11/24/202529.00 TWD
11/21/202528.80 TWD
11/20/202528.90 TWD
11/19/202528.90 TWD
11/18/202528.90 TWD
11/17/202529.00 TWD
11/14/202529.20 TWD
11/13/202529.20 TWD
11/12/202529.55 TWD
11/11/202529.30 TWD
11/10/202529.55 TWD
11/7/202529.90 TWD
11/6/202529.80 TWD
11/5/202530.00 TWD
11/4/202529.85 TWD
11/3/202530.05 TWD
10/31/202530.70 TWD
10/30/202530.60 TWD
10/29/202530.80 TWD
10/28/202530.90 TWD
10/27/202531.00 TWD
10/23/202531.95 TWD
10/22/202532.10 TWD
10/21/202532.05 TWD
10/20/202532.00 TWD
10/17/202532.15 TWD
10/16/202532.00 TWD
10/15/202532.10 TWD
10/14/202531.80 TWD
10/13/202531.90 TWD
10/9/202532.00 TWD
10/8/202532.40 TWD
10/7/202532.35 TWD
10/3/202533.10 TWD
10/2/202532.85 TWD
10/1/202533.15 TWD
9/30/202533.30 TWD
9/26/202533.60 TWD
9/25/202533.95 TWD
9/24/202533.95 TWD
9/23/202533.70 TWD
9/22/202534.10 TWD
9/19/202534.15 TWD
9/18/202534.15 TWD
9/17/202534.20 TWD
9/16/202534.10 TWD
9/15/202534.20 TWD
9/12/202534.20 TWD
9/11/202534.50 TWD
9/10/202534.70 TWD
9/9/202536.00 TWD
9/8/202534.35 TWD
9/5/202533.00 TWD
9/4/202532.70 TWD
9/3/202532.40 TWD
9/2/202532.95 TWD
9/1/202533.60 TWD
8/29/202535.15 TWD
8/28/202530.00 TWD
8/27/202529.95 TWD
Access this data via the Eulerpool API

Revivegen Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
117.85 M TWD
38.26 M TWD
6.56 M TWD
Jan 1, 2019
168.97 M TWD
68.22 M TWD
20.09 M TWD
Jan 1, 2020
196.41 M TWD
16.76 M TWD
11.28 M TWD
Jan 1, 2021
337.00 M TWD
46.64 M TWD
35.57 M TWD
Jan 1, 2022
339.16 M TWD
43.17 M TWD
35.15 M TWD
Jan 1, 2023
393.59 M TWD
30.03 M TWD
40.81 M TWD
Jan 1, 2024
447.86 M TWD
43.11 M TWD
38.50 M TWD
Jan 1, 2025
469.23 M TWD
33.58 M TWD
20.37 M TWD

Revivegen Co Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 26, 2026, 8:29 AM
 
REVENUEM TWD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM TWD
EBITM TWD
EBIT MARGIN%
NET INCOMEM TWD
NET INCOME GROWTH%
DIV.TWD
DIV. GROWTH%
SHARESM
201720182019202020212022202320242025
117.00168.00196.00337.00339.00393.00447.00469.00
43.5916.6771.940.5915.9313.744.92
32.4840.4831.6328.1934.2227.9925.5048.19
226.0038.0068.0062.0095.00116.00110.00114.00226.00
-20.0038.0068.0016.0046.0043.0030.0043.0033.00
32.4840.488.1613.6512.687.639.627.04
-5.006.0020.0011.0035.0035.0040.0038.0020.00
-220.00233.33-45.00218.1814.29-5.00-47.37
1.460.381.00
-73.97163.16
57.2857.2857.2857.2827.6338.8854.5160.7557.28
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Revivegen Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Revivegen Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Revivegen Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Revivegen Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Revivegen Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Revivegen Co stock margins

The Revivegen Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Revivegen Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Revivegen Co.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
32.46 %
32.46 %
5.56 %
Jan 1, 2019
40.37 %
40.37 %
11.89 %
Jan 1, 2020
31.86 %
8.53 %
5.74 %
Jan 1, 2021
28.33 %
13.84 %
10.56 %
Jan 1, 2022
34.21 %
12.73 %
10.36 %
Jan 1, 2023
28.11 %
7.63 %
10.37 %
Jan 1, 2024
25.48 %
9.63 %
8.60 %
Jan 1, 2025
48.33 %
7.16 %
4.34 %

Revivegen Co Stock Revenue, EBIT, Earnings per Share

The Revivegen Co earnings per share therefore indicates how much revenue Revivegen Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
0.00 TWD
0.00 TWD
0.00 TWD
Jan 1, 2019
0.00 TWD
0.00 TWD
0.00 TWD
Jan 1, 2020
0.00 TWD
0.00 TWD
0.00 TWD
Jan 1, 2021
12.20 TWD
1.69 TWD
1.29 TWD
Jan 1, 2022
8.72 TWD
1.11 TWD
0.90 TWD
Jan 1, 2023
7.22 TWD
0.55 TWD
0.75 TWD
Jan 1, 2024
7.37 TWD
0.71 TWD
0.63 TWD
Jan 1, 2025
8.19 TWD
0.59 TWD
0.36 TWD

Revivegen Co business model & stock analysis

Revivegen Co Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Revivegen Co historical P/E ratio, EBIT multiple, and P/S ratio

Revivegen Co annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Revivegen Co shares outstanding

The number of shares of Revivegen Co was 57.28 M in 2025. This indicates how many shares Revivegen Co is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
60.07 M Stocks
Jan 1, 2019
60.07 M Stocks
Jan 1, 2020
60.07 M Stocks
Jan 1, 2021
27.63 M Stocks
Jan 1, 2022
38.88 M Stocks
Jan 1, 2023
54.51 M Stocks
Jan 1, 2024
60.75 M Stocks
Jan 1, 2025
57.28 M Stocks

Revivegen Co stock splits

In Revivegen Co's history, there have been no stock splits.

Revivegen Co Dividend History

3 years of dividend payments

YearAnnual DividendYoY ChangePayments
20250.50TWD 32.9%
Jul 22, 20250.50TWD 184.5%1/1
20240.38TWD 55.1%
20230.84TWD

Revivegen Co dividend history and estimates

In 2025, Revivegen Co paid a dividend amounting to 0.50 TWD. Dividend means that Revivegen Co distributes a portion of its profits to its owners.
  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2023 (e)
0.84 TWD
0.62 TWD
Jan 1, 2024
0.38 TWD
0.00 TWD
Jan 1, 2025 (e)
0.50 TWD
0.50 TWD

Revivegen Co dividend payout ratio

In 2025, Revivegen Co had a payout ratio of 140.37%. The payout ratio indicates the percentage of the company's profits that Revivegen Co distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
100.29 %
Jan 1, 2019
100.29 %
Jan 1, 2020
100.29 %
Jan 1, 2021
100.29 %
Jan 1, 2022
100.29 %
Jan 1, 2023
97.38 %
Jan 1, 2024
63.12 %
Jan 1, 2025
140.37 %
Price targets and forecasts for Revivegen Co are not yet available.

Revivegen Co Executives and Management Board

12 members · avg. age 68 · 11 % women

Management

ML

Mr. Mingxian Lin

Deputy General Manager-R&D and Innovation Division

ZL

Mr. Zhendong Liu

Deputy General Manager-Technology Division

SY

Ms. Shufen Yang

Deputy General Manager-Management Division, Corporate Governance Officer

Board of Directors

ZZ

Mr. Zhengyou Zhong

Chairman of the Board, General Manager · since 2017

KC

Mr. Kuanrong Chen

Director

YL

Mr. Yu-lung Lin

Director

WZ

Wenhan Zhang

Director

ZZ

Mr. Zhengguang Zhang

Director

ZC

Zongde Chen

Independent Director

Frequently asked questions about Revivegen Co

Converted at the current exchange rate, the Revivegen Co share trades at 0.68 EUR (25.20 TWD).

No history available for Revivegen Co.

The revenue cannot currently be calculated for Revivegen Co.

The profit cannot currently be calculated for Revivegen Co.

The P/E ratio cannot be calculated for Revivegen Co at the moment.

The P/S cannot be calculated for Revivegen Co currently.

The Eulerpool Quality Score for Revivegen Co is 2/10.

The ISIN of Revivegen Co is TW0007578B14. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Revivegen Co is 7578.TWO. The ticker symbol is used to trade Revivegen Co shares on the stock exchange.

Over the past 12 months, Revivegen Co paid a dividend of 0.50 TWD . This corresponds to a dividend yield of about 1.98 %. For the coming 12 months, Revivegen Co is expected to pay a dividend of 0.50 TWD.

The current dividend yield of Revivegen Co is 1.98 %.

Revivegen Co pays a dividend, distributed in the months of , , , .

Revivegen Co paid dividends every year for the past 3 years.

For the upcoming 12 months, dividends amounting to 0.50 TWD are expected. This corresponds to a dividend yield of 1.98 %.

Revivegen Co is assigned to the 'Industry' sector.

To receive the latest dividend of Revivegen Co from amounting to 0.5 TWD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Revivegen Co distributed 0.4 TWD as dividends.

The dividends of Revivegen Co are distributed in TWD.

All fundamentals and in-depth analysis of Revivegen Co

Our stock analysis for Revivegen Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Revivegen Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.